Inmode Ltd

INMD’s Stage 2 advance with a confirmed higher-high/higher-low sequence and active Lockout Rally dynamics supports continued upside despite a longer-term downtrend. Price is extended and overbought, but institutional short-covering under the Lockout Rally override permits immediate participation. Under the Free Cash Flow + Buybacks strategy, the recommended posture is Buy Now into the rising EMAs.

• ↑Market leader in minimally invasive aesthetic devices; launched new CO2 lasers
• ↑Q1 2026 revenue $82 M (+5% YoY); international sales 48% of total
• ↓Q1 2026 revenue fell 6% YoY to $82 M; GAAP EPS $0.18 vs. $0.26